HIRNMETASTASIERUNGBEIMMAMMAKARZINOM C79.3
Conditions
Interventions
Group 1: BMBC Registry
-Clinical data of patients with brain metastases and breast cancer
-Establishment of a biobank for the translational research
Sponsors
Principal InvestigatorKlinik und Poliklinik für Gynäkologie Universitätsklinikum Hamburg-Eppendorf
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Patients with brain metastases and a history of breast cancer,diagnosis of brain metastases since the year 2000.
Exclusion criteria
Exclusion criteria: Patients with any other malignant disease, patients with no histological verification of the diagnosis of breast cancer, patients with a neurological disease, patients with exclusively leptomeningeal disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identification of risk-groups for brain metastases and treatment regimens in a patient collective | — |
Secondary
| Measure | Time frame |
|---|---|
| -Determination of the incidence of brain metastases - Number and size of brain metastases - Location of brain metastases - Histopathological characteristics of the primary tumour and brain metastases - Sensitivity of diagnostic tools (CT, MRI) - Performance status and prognosis - Influence of treatment strategies on prognosis - Collection of tissue samples of the primary tumour, metastatic tissue and brain tissue. - quality of life after diagnosis of brain metastases - neurological function depending on treatment strategies | — |
Countries
Germany
Contacts
Public ContactBirgit Raasch
German Breast Group Forschungs GMBH
Outcome results
None listed